Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $885.02 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $414.47 | 4 | $0 (2023) |
| Alkermes, Inc. | $136.15 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $135.42 | 5 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $125.00 | 1 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $39.07 | 1 | $0 (2023) |
| Neuronetics, Inc. | $19.67 | 1 | $0 (2018) |
| AbbVie Inc. | $15.24 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $152.23 | 3 | Alkermes, Inc. ($136.15) |
| 2023 | $191.78 | 3 | Janssen Pharmaceuticals, Inc ($137.47) |
| 2022 | $265.98 | 4 | Janssen Pharmaceuticals, Inc ($182.65) |
| 2019 | $94.35 | 1 | Janssen Pharmaceuticals, Inc ($94.35) |
| 2018 | $19.67 | 1 | Neuronetics, Inc. ($19.67) |
| 2017 | $161.01 | 3 | Neurocrine Biosciences, Inc. ($125.00) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: PSYCHIATRY | ||||||
| 03/28/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $115.51 | General |
| Category: CNS | ||||||
| 02/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: CNS | ||||||
| 11/17/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $39.07 | General |
| Category: Neurology | ||||||
| 05/02/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $137.47 | General |
| Category: Neuroscience | ||||||
| 09/01/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Neuroscience | ||||||
| 07/11/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: PSYCHIATRY | ||||||
| 06/23/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $57.67 | General |
| Category: Neuroscience | ||||||
| 05/12/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $63.98 | General |
| Category: PSYCHIATRY | ||||||
| 06/13/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $94.35 | General |
| Category: Neuroscience | ||||||
| 06/20/2018 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 12/05/2017 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROLOGY | ||||||
| 08/31/2017 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $24.41 | General |
| 02/01/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 11 | 13 | $1,885 | $593.12 |
| 2021 | 7 | 240 | 418 | $57,101 | $19,677 |
| 2020 | 3 | 84 | 125 | $26,613 | $7,387 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 13 | $1,885 | $593.12 | 31.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 72 | 120 | $18,715 | $6,248 | 33.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 71 | 173 | $14,059 | $5,061 | 36.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 37 | 40 | $9,134 | $3,097 | 33.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Facility | 2021 | 18 | 42 | $5,684 | $2,054 | 36.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 15 | $4,407 | $1,301 | 29.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 13 | 14 | $3,072 | $1,142 | 37.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 14 | 14 | $2,030 | $774.06 | 38.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 33 | 40 | $12,164 | $3,294 | 27.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 38 | 56 | $11,494 | $3,194 | 27.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 13 | 29 | $2,955 | $898.38 | 30.4% |
About Dr. Brent Coyle, M.D
Dr. Brent Coyle, M.D is a Psychiatry healthcare provider based in Bristol, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275507642.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brent Coyle, M.D has received a total of $885.02 in payments from pharmaceutical and medical device companies, with $152.23 received in 2024. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($885.02).
As a Medicare-enrolled provider, Coyle has provided services to 335 Medicare beneficiaries, totaling 556 services with total Medicare billing of $27,656. Data is available for 3 years (2020–2022), covering 11 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry, Psychiatry
- Location Bristol, VA
- Active Since 02/14/2006
- Last Updated 01/02/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275507642
Products in Payments
- SPRAVATO (Drug) $262.45
- INVEGA SUSTENNA (Drug) $152.02
- ARISTADA (Drug) $136.15
- INGREZZA (Drug) $125.00
- REXULTI (Drug) $63.98
- ABILIFY MAINTENA (Drug) $47.03
- UZEDY (Drug) $39.07
- NEUROSTAR TMS THERAPY (Device) $19.67
- VRAYLAR (Drug) $15.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Bristol
Manoharan Nachiyappan, Md, MD
Psychiatry — Payments: $4,480
Ranjan Sinha, M.d, M.D
Psychiatry — Payments: $3,071
Frederick Reindel, Md, MD
Psychiatry — Payments: $3,047
Dr. Rajani Patel, Md, MD
Psychiatry — Payments: $2,277
Safia Sabri, Md, MD
Psychiatry — Payments: $731.32
Dr. Diane Hawkins, Md, MD
Psychiatry — Payments: $702.52